{"public_id":"cl_eb044e6c9cd66ca20672653115c76c70","status":"active","superseded_by_public_id":null,"corpus_id":205906485,"text":"Cenicriviroc and placebo produced similar rates of NAS improvement and steatohepatitis resolution at year 1 in the intent-to-treat population.","confidence":0.96,"paper":{"corpus_id":205906485,"title":"A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","url":"https://sah.borca.ai/papers/205906485"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_36210605ade2af18157939082e218a06","name":"cenicriviroc","description":"A dual antagonist of C-C chemokine receptor types 2 and 5 evaluated as a treatment for nonalcoholic steatohepatitis with fibrosis.","types":["drug","therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_36210605ade2af18157939082e218a06"},{"public_id":"co_d3021bb2e26af01a051aead3fca986fb","name":"nonalcoholic steatohepatitis","description":"An inflammatory form of nonalcoholic fatty liver disease characterized by liver injury and steatosis.","types":["disease","condition"],"url":"https://sah.borca.ai/concepts/co_d3021bb2e26af01a051aead3fca986fb"},{"public_id":"co_f38f9a7bbeff00033b79921dbb99b7a6","name":"nonalcoholic fatty liver disease activity score","description":"A composite histologic score used to assess disease activity in nonalcoholic steatohepatitis.","types":["measurement","clinical score"],"url":"https://sah.borca.ai/concepts/co_f38f9a7bbeff00033b79921dbb99b7a6"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_eb044e6c9cd66ca20672653115c76c70"}